Lipid Signaling in Human Diseases

Lieferzeit: Lieferbar innerhalb 14 Tagen

160,49 

Handbook of Experimental Pharmacology 259

ISBN: 3030336700
ISBN 13: 9783030336707
Herausgeber: Julian Gomez-Cambronero/Michael A Frohman
Verlag: Springer Verlag GmbH
Umfang: xiv, 336 S., 20 s/w Illustr., 30 farbige Illustr., 336 p. 50 illus., 30 illus. in color.
Erscheinungsdatum: 25.04.2021
Auflage: 1/2020
Produktform: Kartoniert
Einband: KT

Reviews the current status of the field of lipid signaling focused on translational significance with the prospect to be clinically relevant for human diseaseThe book combines both basic principles and applied agents with clinical significance for lipid cell signaling, phospholipases and lipid kinases, lipid metabolism and trafficking, and bioactive lipidsDrug development and novel application ideas are incorporated where possible

Artikelnummer: 1748984 Kategorie:

Beschreibung

Lipids are an integral part of cell membrane architecture, are intermediaries in cell metabolism, and are involved in transmitting cell signals from hormones, growth factors and nutrients. A number of lipases and phospholipases, lipid kinases, lipid phosphatases, sphingosine kinases, and their reaction products have been implicated in fundamental cellular processes including cell proliferation, division and migration. These enzymes and their products underlie the molecular mechanisms of numerous human diseases, in particular metabolic disease (diabetes), cancer, neurodegenerative disease and cardiovascular disease.Over the last decade, studies have advanced to the point that a number of inhibitors for these enzymes have been developed to attempt to ameliorate these conditions; some of the inhibitors are currently in human clinical trial. The need for this book is to review the current status of this field and the prospect for the inhibitors to be clinically important.

Das könnte Ihnen auch gefallen …